CAR T Cells: Expanding into Numerous Myeloma June 12, 2017, by NCI Staff Before (left) and after (right) PET scans of a patient with numerous myeloma treated with BCMA-targeted CAR T cells. Results from two early-phase clinical trials suggest that a form of immunotherapy that uses genetically engineered immune cells may be very effective in […]